DCM
ZBH icon

Diag Capital Management’s Zimmer Biomet ZBH Stock Holding History

Diag Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$4.95M Buy
+49,115
New +$5.52M 5.66% 3

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Diag Capital Management's ZBH Position: Q4 2018 in Review

Diag Capital Management opened a new position in Zimmer Biomet (ZBH) in Q4 2018: 49,115 shares worth $4.95M. The stake represents 5.66% of the portfolio and ranks #3 among its holdings.

872 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

  • Diag Capital Management held 49,115 shares of Zimmer Biomet worth $4.95M as of Q4 2018.
  • Zimmer Biomet was a new Diag Capital Management position in Q4 2018.
  • Zimmer Biomet made up 5.66% of Diag Capital Management's portfolio in Q4 2018, its #3 holding.
  • 872 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.